The Antenatal Companion

GP Shared Care Decision Support · Australian Guidelines

Reference Mater Mothers' V5 (May 2025)
Aust. Pregnancy Care Guidelines (Feb 2025)
RANZCOG · SOMANZ · Qld Clinical Guidelines
Section one

Patient profile

Calendar picker · auto-calculates GA & EDD
Auto from LMP · override if USS-dated
LMP + 280 days
BMI: — kg/m²
Section two

Clinical risk factors

Current visit

Gestation— wks
EDD
Trimester
Next visit

Quick reference

Diagnostic thresholds · Always visible

i.

Gestational diabetes

First trimester HbA1c≥ 41 mmol/mol (5.9%)
OGTT fasting≥ 5.1 mmol/L
OGTT 1-hour≥ 10.0 mmol/L
OGTT 2-hour≥ 8.5 mmol/L
BGL targets — fasting≤ 5.0 mmol/L
BGL targets — 1hr post-meal≤ 7.4 mmol/L
Routine OGTT 24–28 weeks. Early HbA1c if high risk (BMI >30, age ≥40, prev GDM, PCOS, ethnicity, prev macrosomia, family Hx, PCOS, antipsychotics/corticosteroids).
ii.

Hypertension & pre-eclampsia

Hypertension≥ 140/90 mmHg
Significant rise+30/15 mmHg from baseline
Proteinuria (PCR)≥ 30 mg/mmol
Dipstick protein≥ 2+
Aspirin prophylaxis100–150mg nocte from 12w
PlGF screening11+0 to 13+6 weeks
Refer to PAC: BP ≥140/90 + symptoms, abnormal pathology, IUGR or proteinuria. Severe range BP ≥160/110 — urgent.
iii.

Anaemia in pregnancy

Hb (T1 / T3)< 105 g/L
Hb (T2)< 110 g/L
Iron deficiency (ferritin)< 30 µg/L
Oral iron (deficiency anaemia)100–200mg elemental/day
Oral iron (deficiency w/o anaemia)20–80mg elemental/day
IV iron — consider ifHb <100 >36w OR Hb <90 >32w
Reassess Hb + ferritin 4 weeks after starting oral iron. IV iron NOT before 13 weeks. Take iron away from dairy/tea/multivitamins.
iv.

Anti-D protocol (Rh negative)

Free fetal DNA Rh DFrom 15 weeks
Sensitising event <12w250 IU (625 if multiple)
Sensitising event ≥12w625 IU + FMH ≥20w
Routine prophylaxis625 IU at 28 + 34 weeks
Postnatal (baby Rh+)625 IU within 72h
Repeat antibody screenBefore 28w dose
No Anti-D if fetus confirmed Rh negative on NIPT. Cord blood at birth always confirms neonatal Rh. Threatened miscarriage is NOT a sensitising event.
v.

Scan & screening timings

Dating USS (ideal)7–8w (CRL ≥10mm)
NIPT (blood)From 10 weeks
CFTS bloods (PAPP-A, βhCG)10+0 to 13+6w
Nuchal translucency USS11+3 to 13+6w
PlGF (early PE screen)11+0 to 13+6w
Free fetal DNA Rh D (if Rh−)From 15 weeks
Morphology USS18–22 weeks
NIPT preferred over CFTS when affordable. Carrier screening Medicare-funded once per lifetime. Refer Mater MFM for CVS/amnio.
Clinical Note Copied to Clipboard!